Grupa Modne ZakupyWAR:GMZ 27 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:GMZ with a GF Score™ of 27/100. The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Grupa Modne Zakupy ranks worse than 98.65% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Grupa Modne Zakupy's EBITDA for the
three
months ended in Mar. 2026 was zł-0.16 Mil. Grupa Modne Zakupy's Revenue for the
three
months ended in Mar. 2026 was zł0.00 Mil. Therefore, Grupa Modne Zakupy's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.
Grupa Modne Zakupy (WAR:GMZ) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Grupa Modne Zakupy EBITDA Margin % Related Terms
Grupa Modne Zakupy EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Grupa Modne Zakupy's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:GMZ vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Grupa Modne Zakupy's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grupa Modne Zakupy EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Grupa Modne Zakupy's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Grupa Modne Zakupy's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grupa Modne Zakupy (WAR:GMZ) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grupa Modne Zakupy and its competitors. According to the industry distribution chart, Grupa Modne Zakupy ranks #805 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 98.7%.
Is Grupa Modne Zakupy's EBITDA Margin % too high?
Grupa Modne Zakupy's current EBITDA Margin % is 0.00%. Based on the distribution chart, Grupa Modne Zakupy ranks #805 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Grupa Modne Zakupy has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Grupa Modne Zakupy's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Grupa Modne Zakupy ranks #805 out of 816 companies for EBITDA Margin %. This places Grupa Modne Zakupy in the lower half of its industry. The industry median EBITDA Margin % is 7.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grupa Modne Zakupy and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grupa Modne Zakupy's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grupa Modne Zakupy stock overvalued right now?
Grupa Modne Zakupy (WAR:GMZ) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Grupa Modne Zakupy's overall GF Score™ is 27/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Grupa Modne Zakupy (WAR:GMZ), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Grupa Modne Zakupy SA, formerly Infoscan SA is engaged in the research and development of medical instruments and diagnostics technologies. The company offers remote diagnostics of breathing disorders during sleep.
27GF Score
Get the complete analysis for WAR:GMZ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:GMZ has been successfully added to your 
